Vapotherm, Inc. (VAPO)
Chart Events
Performance Outlook
| Previous Close | 1.8000 |
| Open | 1.8000 |
| Bid | 1.8300 x 800 |
| Ask | 1.8500 x 900 |
| Day's Range | 1.8000 - 1.9200 |
| 52 Week Range | 1.6600 - 31.8700 |
| Volume | |
| Avg. Volume | 363,974 |
| Market Cap | 47.713M |
| Beta (5Y Monthly) | -0.18 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.2610 |
| Earnings Date | Feb 22, 2022 - Feb 28, 2022 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.83 |
- Business Wire
Vapotherm to Participate in the Canaccord Genuity 42nd Annual Growth Conference
EXETER, N.H., August 04, 2022--Vapotherm, Inc. (NYSE: VAPO), ("Vapotherm" or the "Company"), a global medical technology company focused on the development and commercialization of its proprietary Vapotherm high velocity therapy® products, which are used to treat patients of all ages suffering from respiratory distress, today announced that its management team will be participating in the Canaccord Genuity 42nd Annual Growth Conference on Thursday, August 11, 2022 via webcast.
- Zacks
Vapotherm (VAPO) Reports Q2 Loss, Lags Revenue Estimates
Vapotherm (VAPO) delivered earnings and revenue surprises of -7.69% and 32.93%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
- Business Wire
Vapotherm Reports Second Quarter 2022 Financial Results
EXETER, N.H., August 03, 2022--Vapotherm, Inc. (NYSE: VAPO), ("Vapotherm" or the "Company"), today announced second quarter 2022 financial results.
